Related news from
Mon, 27 Apr 2026 17:31:00 +0000	Cardinal Health Pre-Q3 Analysis: Buy, Hold or Sell the Stock Now? CAH's Q3 results are likely to benefit from strong specialty momentum and GMPD progress, but tougher comps and tariff pressures may test upside.
Mon, 27 Apr 2026 11:02:00 +0000	CareMetx Acquires U.S.-based Patient Services and Free Goods Pharmacy Operations from Cencora, Significantly Expanding Its Patient Access Platform As demand for technology-forward patient services accelerates, combined organization positions CareMetx to deliver greater innovation for biopharma clients.BETHESDA, MD, April 27, 2026 (GLOBE NEWSWIRE) -- CareMetx, the market-leading technology-enabled patient services provider, today announced the acquisition of Cencora's U.S. Hub consulting services operations previously conducted under the Lash Group and including TheraCom free goods pharmacy. The transaction substantially increases CareMetx'
Fri, 24 Apr 2026 16:28:54 +0000	Cencora, Inc. (COR) Expands Into Retina Services Business in $1.1B Deal Cencora, Inc. (NYSE:COR) is one of the stocks positioned for breakout growth. On March 24, UBS reiterated a Buy rating on Cencora, Inc. (NYSE:COR) with a $410 price target. The bullish stance is in response to the company’s announcement of the acquisition of EyeSouth’s partner’s retina business for $1.1 billion. The acquisition marks an important […]
Thu, 23 Apr 2026 23:33:23 +0000	1 of Wall Street’s Favorite Stock to Target This Week and 2 Facing Challenges Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Thu, 23 Apr 2026 14:30:00 +0000	RIS Rx Welcomes Industry Pioneer Tom Doyle as Senior Advisor IRVINE, Calif., April 23, 2026--RIS Rx welcomes Tom Doyle as Senior Advisor, strengthening its leadership in real-time GTN Revenue Protection for pharmaceutical manufacturers.
Mon, 20 Apr 2026 16:12:58 +0000	McKesson Stock: A Compounding Engine Facing Its Critical Test McKesson’s net income grew at an average rate of 14.4% over the last three years, yet its earnings per share (EPS) increased by 19.6% annually during that same window. This 5.2% gap represents the additional value management captured for shareholders through a consistent strategy.
Mon, 20 Apr 2026 04:18:19 +0000	Cencora Retina Deal Deepens Specialty Eye Care And Earnings Story Cencora (NYSE:COR) has agreed to acquire the retina business of EyeSouth Partners. The deal expands Cencora's specialty eye care operations and broadens its clinical network. The transaction focuses on retina services, a key area within ophthalmology care. Cencora operates as a pharmaceutical solutions organization with a focus on specialty distribution and services, and the move into EyeSouth Partners' retina business fits within that profile. Specialty eye care sits at the intersection of...
Fri, 17 Apr 2026 07:36:56 +0000	What You Need to Know Ahead of Cencora's Earnings Release Cencora is scheduled to report its second-quarter results next month, and analysts project a single-digit increase in earnings.
Thu, 16 Apr 2026 11:00:00 +0000	Soleo Health Appoints Joy Rowan as New Senior Vice President of Sales to Drive Strategic Growth Initiatives FRISCO, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, today announced the appointment of Joy Rowan, MS, MBA to the role of senior vice president, sales. Reporting to the chief commercial officer, Rowan will lead the Company’s field sales organization to accelerate commercial performance and deliver on its strategic growth initiatives. With over 25 years of industry experience and a proven track record of
Thu, 16 Apr 2026 10:00:00 +0000	Camino Corporation Commences Drilling at Costa de Cobre District-Scale IOCG Copper Discovery in Peru VANCOUVER, BC / ACCESS Newswire / April 16, 2026 /Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce the commencement of a drilling campaign at its Costa de Cobre district-scale IOCG copper discovery ...
Mon, 13 Apr 2026 12:00:00 +0000	Dario Appoints Veteran Healthcare Executive John R. Palumbo to Board of Directors to Support Accelerated Commercial Scaling DarioHealth Corp. (NASDAQ: DRIO) (the "Company" or "Dario"), a leader in global digital health, today announced the appointment of John R. Palumbo to its Board of Directors. The addition reflects Dario's continued alignment of board composition with its next phase of commercial scaling.
Mon, 13 Apr 2026 08:04:47 +0000	Assessing Cencora (COR) Valuation As Short Term Momentum Cools And Long Term Returns Remain Strong Cencora (COR) has been drawing attention after recent share price volatility, with the stock down about 8% over the past month and roughly 7% over the past 3 months from its last close of $320.82. See our latest analysis for Cencora. Despite the recent weak patch in the share price, with a 30 day share price return of 8.32% and 90 day share price return of 7.25%, longer term total shareholder returns of 13.66% over 1 year and 183.05% over 5 years show that investors who stayed invested have...
Mon, 06 Apr 2026 12:53:20 +0000	Is Medline Inc. (MDLN) A Good Stock To Buy Now? Is MDLN a good stock to buy? We came across a bullish thesis on Medline Inc. on The Pursuit of Compounding’s Substack. In this article, we will summarize the bulls’ thesis on MDLN. Medline Inc.’s share was trading at $41.36 as of March 27th. MDLN’s trailing and forward P/E were 29.91 and 29.24 respectively according to Yahoo Finance. Medline Industries (MDLN) […]
Thu, 02 Apr 2026 14:00:20 +0000	2 S&P 500 Stocks with Exciting Potential and 1 We Ignore The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Wed, 01 Apr 2026 20:30:00 +0000	Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release CONSHOHOCKEN, Pa., April 01, 2026--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2026 on Wednesday, May 6, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 6, 2026.
Wed, 01 Apr 2026 14:27:00 +0000	Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth? CAH's specialty flywheel strategy links distribution, MSOs and biopharma services, boosting partnerships, drug launches and recurring revenue potential.
Tue, 31 Mar 2026 10:21:19 +0000	1 Large-Cap Stock for Long-Term Investors and 2 We Avoid Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
Tue, 31 Mar 2026 05:03:35 +0000	Is It Time To Reassess Cencora (COR) After The Recent Share Price Pullback? Investors may be wondering whether Cencora is attractively priced after its recent run and pullback, or if the stock is now reflecting too much optimism. The share price closed at US$309.93, with a 3.3% decline over the last 7 days and a 16.7% decline over the last 30 days. This is set against a 12.2% return over 1 year and very strong returns over 3 and 5 years. Recent coverage has focused on Cencora as a key healthcare distributor and supply chain player, with attention on how it fits into...
Mon, 30 Mar 2026 11:39:57 +0000	Cencora, Inc. (COR) Signs Binding Agreement to Expand Retina Network With EyeSouth Acquisition We recently compiled a list of the 13 Best Stocks to Invest In on Robinhood for Beginners. Cencora, Inc. is the next best Robinhood stock on this list. TheFly reported on March 23 that COR revealed that it has signed a binding agreement to acquire the retina division of EyeSouth Partners for $1.1 billion. Once the […]
Thu, 26 Mar 2026 14:57:21 +0000	Reflecting On Health Insurance Providers Stocks’ Q4 Earnings: Cencora (NYSE:COR) As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at health insurance providers stocks, starting with Cencora (NYSE:COR).

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!